Bicillin L-A (penicillin G benzathine injectable suspension) recall — Class II (D-0545-2025) · pharmaranks
Class IIOngoing
Bicillin L-A (penicillin G benzathine injectable suspension) recall
FDA recall D-0545-2025 · initiated Jul 10, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
CGMP Deviations; particulates identified during visual inspection
Details
Product
Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.